SANOFICONR Stock Chart & Stats
₹4722.55
₹33.30(0.69%)
At close: 4:00 PM EST
₹4722.55
₹33.30(0.69%)
Day’s Range― - ―
52-Week Range₹3,950.50 - ₹5,568.95
Previous CloseN/A
Volume217.00
Average Volume (3M)257.00
Market Cap
₹106.62B
Enterprise Value₹105.97B
Total Cash (Recent Filing)₹3.75B
Total Debt (Recent Filing)₹248.00M
Price to Earnings (P/E)41.2
Beta0.31
Next Earnings
Aug 10, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.22%
Share Statistics
EPS (TTM)55.23
Shares Outstanding23,030,622
10 Day Avg. Volume341
30 Day Avg. Volume257
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)27.14
Price to Sales (P/S)11.87
P/FCF Ratio57.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)120
Revenue Forecast (FY)₹9.87B
SANOFICONR FAQ
What was Sanofi Consumer Healthcare India Limited’s price range in the past 12 months?
Sanofi Consumer Healthcare India Limited lowest stock price was ₹3950.50 and its highest was ₹5568.95 in the past 12 months.
What is Sanofi Consumer Healthcare India Limited’s market cap?
Sanofi Consumer Healthcare India Limited’s market cap is ₹106.62B.
When is Sanofi Consumer Healthcare India Limited’s upcoming earnings report date?
Sanofi Consumer Healthcare India Limited’s upcoming earnings report date is Aug 10, 2026 which is in 35 days.
How were Sanofi Consumer Healthcare India Limited’s earnings last quarter?
Sanofi Consumer Healthcare India Limited released its earnings results on Apr 28, 2026. The company reported ₹29.5 earnings per share for the quarter, beating the consensus estimate of N/A by ₹29.5.
Is Sanofi Consumer Healthcare India Limited overvalued?
According to Wall Street analysts Sanofi Consumer Healthcare India Limited’s price is currently Overvalued.
Does Sanofi Consumer Healthcare India Limited pay dividends?
Sanofi Consumer Healthcare India Limited pays a Notavailable dividend of ₹75 which represents an annual dividend yield of 1.22%. See more information on Sanofi Consumer Healthcare India Limited dividends here
What is Sanofi Consumer Healthcare India Limited’s EPS estimate?
Sanofi Consumer Healthcare India Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sanofi Consumer Healthcare India Limited have?
Sanofi Consumer Healthcare India Limited has 23,030,622 shares outstanding.
What happened to Sanofi Consumer Healthcare India Limited’s price movement after its last earnings report?
Sanofi Consumer Healthcare India Limited reported an EPS of ₹29.5 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.591%.
Which hedge fund is a major shareholder of Sanofi Consumer Healthcare India Limited?
Currently, no hedge funds are holding shares in IN:SANOFICONR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sanofi Consumer Healthcare India Limited
Sanofi Consumer Healthcare India Limited, an Indian company founded in 2023 and based in Mumbai, specializes in fast-moving consumer healthcare products. The firm's offerings cover categories such as allergy relief, overall well-being, and pain management, featuring prominent brands like Allegra, Combiflam, Avil, DePURA, Festal, and Novalgin NU. These products are distributed through a comprehensive network that includes distributors, wholesalers, government institutions, hospitals, pharmacies, pharmacy chains, and e-commerce platforms. The company operates as a subsidiary of Opella Healthcare Participations B.V.
Technical Analysis
Abbott India Limited
―
Cipla Ltd
―
GlaxoSmithKline Pharmaceuticals Limited
―
PFIZER LIMITED
―
TTK Healthcare Limited
―







